艾滋病毒感染者的慢性阻塞性肺病:基于证据的审查
Andrew T Read1, Jane Akodu2, Tristan J Barber2,3
1Respiratory Medicine, Royal Free London NHS Foundation Trust, London, UK.
HIV/AIDS (Auckland, N.Z.)
|June 18, 2025
概括
患有人类免疫缺陷病毒 (HIV) 的人患慢性阻塞性肺病 (COPD) 的风险更高. 艾滋病毒加快了COPD的进展,可能需要独特的管理策略超越戒烟.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 同时感染艾滋病毒是慢性阻塞性肺病 (COPD) 的新兴风险因素.
- 艾滋病毒通过与吸烟,污染和感染等环境因素的相互作用加剧了COPD的发展.
- 艾滋病毒通过氧化应激,炎症,免疫功能障碍和表观遗传变化独立地促进COPD的病原性.
研究的目的:
- 审查与艾滋病毒相关的COPD的流行病学和病理生理学.
- 讨论当前和潜在的预防和治疗艾滋病毒相关的COPD的策略.
主要方法:
- 这是一篇综述性文章,综合了有关艾滋病毒相关的COPD的现有研究.
- 该审查涵盖流行病学数据,病原遗传机制和临床管理.
主要成果:
- 艾滋病毒感染者在较年轻时更频繁地患上COPD,并经历更快的肺功能下降.
- 与艾滋病毒相关的COPD可能呈现出明显的肺功能异常模式.
- 当前的治疗策略通常是从一般的COPD患者群体中推断出来的.
结论:
- 艾滋病毒显著影响COPD的发展和进展,需要对量身定制的干预措施有更深入的了解.
- 虽然戒烟至关重要,但对于与艾滋病毒相关的COPD需要独特的管理策略.
- 对艾滋病毒相关的COPD的具体机制和临床过程进行进一步的研究是必不可少的.
相关概念视频
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K


